Mayne Pharma
Manufacturing · Australia · 201-500 Employees
View Company Info for Free
Overview
Headquarters
1538 Main North Rd, Salisbury South, Sou...Phone Number
+61 882092666Website
www.maynepharma.comRevenue
$403.6 MillionStock Symbol
MYX.AXIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
3
1
1
1
1
About Mayne Pharma
Mayne Pharma Group Limited is an ASX-listed specialty pharmaceutical company headquartered in Salisbury South, South Australia, Australia, with U.S. operations based in Raleigh, North Carolina. The company focuses on the commercialization of branded and generic pharmaceuticals, with core therapeutic areas spanning women's health, dermatology, and infectious disease. Mayne Pharma operates through three business segments Women's Health, Dermatology, and International distributing products across Australia, New Zealand, the United States, Canada, Europe, and Asia. The company also offers full-service contract development and manufacturing (CDMO) capabilities, specializing in novel oral and topical dose forms, including pharmaceutical development, analytical testing, and commercial manufacturing for clients worldwide. With over 40 years of experience in developing oral drug delivery systems, Mayne Pharma markets a broad portfolio of branded and generic products under names such as NextstelRead more
Mayne Pharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Mayne Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Mayne Pharma
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Mayne Pharma recently announced quarterly report
Click to see if Mayne Pharma had a recent Job posting/layoffs
Check if Mayne Pharma has recently received funding, and reach out quickly before it becomes old news!
Mayne Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Mayne Pharma is spiking on competitors!
Product Launch: Get notified when Mayne Pharma launches new products
Funding: Get notified immidiatlly once Mayne Pharma has new funding data
Recommended Actions
Reach out to Masked Content who joined Mayne Pharma as Masked Content
Find 3 more new buyers
Compare Similar Companies to Mayne Pharma
Compare insights from companies similar to Mayne Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Mayne Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Mayne Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Mayne Pharma.
Mayne Pharma financials insights
Gather financial insights about Mayne Pharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Debt
$125M
Mayne Pharma Tech Stack
A closer look at the technologies used by Mayne Pharma
See more technologies
Most Recent Scoops
Person-Based
Facilities Relocation/Expansion, Sales
Hiring Plans
Mayne Pharma has more open roles in Engineering & Technical than it has had at any time in the past 6 months. Technologies mentioned include: SQL, Microsoft Fabric, Power BI, and Git with an increased focus that include Performance Improvement, and Analytics.
Hiring Plans
Open Position
Person-Based
Pharmaceuticals, Corporate Strategy
Person-Based
Mayne Pharma News & Media
Mayne Pharma Group Ltd (MAYNF) (H1 2026) Earnings Call Highlights: Strategic Growth Amidst ...
Mayne Pharma Group Ltd (MAYNF) reports strong gross margin improvements and strategic advancements in Women's Health and Dermatology, despite facing competitive and legal challenges.Mayne Pharma CEO Shawn Patrick O'Brien replaced by CFO Aaron Gray - Capital Brief
Mayne Pharma CEO Shawn Patrick O’Brien stepped down on 20 February and has been replaced by CFO Aaron Gray in the wake of its collapsed $600 million deal to be acquired by Cosette Pharmaceuticals.Mayne Pharma Group Limited (MAYNF) Shareholder/Analyst Call Transcript
Mayne Pharma Group Limited (MAYNF) Shareholder/Analyst Call January 28, 2026 6:00 PM ESTCompany ParticipantsBruce G.Summer Moon Capital Statement on FIRB Blocking of Mayne Pharma-Cosette Acquisition
Key Facts: FIRB's preliminary decision to block Cosette Pharmaceuticals' A$672 million acquisition of Mayne Pharma will cause hundreds of millions of dollars of unjustified losses to Australian shareholders The Adelaide manufacturing facility remains profitable and operational, employing 200 people and having recently received an A$18 million upgrade No national security concerns were cited in the
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Mayne Pharma
Sign Up For FreeTo access detailed company insights
Mayne Pharma Group Limited is an ASX-listed specialty pharmaceutical company headquartered in Salisbury South, South Australia, Australia, with U.S. operations based in Raleigh, North Carolina. The company focuses on the commercialization of branded and generic pharmaceuticals, with core therapeutic areas spanning women's health, dermatology, and i... Read More
